<DOC>
	<DOCNO>NCT00059111</DOCNO>
	<brief_summary>To identify early effect obstructive sleep apnea cardiovascular system child .</brief_summary>
	<brief_title>Mechanisms Mediating Cardiovascular Disease Children With Obstructive Sleep Apnea</brief_title>
	<detailed_description>BACKGROUND : Obstructive sleep apnea ( OSA ) important clinical disorder occur men , woman , child prevalence 4 percent , 2 percent 1-3 percent , respectively . OSA active study adult definitely link increased cardiovascular morbidity , even mild moderate clinical form . In contrast , OSA well study child potential deleterious consequence cardiovascular function receive little attention . DESIGN NARRATIVE : The study examine child 1 ) The interaction OSA baroreflex dysfunction , 2 ) The relation OSA severity baroreflex dysfunction abnormality blood pressure control wakefulness sleep , 3 ) The association diminish baroreflex gain impair blood pressure control index end organ damage , leave ventricular mass index , 4 ) Whether effective treatment OSA result significant improvement baroreceptor function , blood pressure control decrease leave ventricular mass index . A cross-sectional study conduct 8-12 year old child OSA match group normal child . Studies include baroreceptor function , 24-hour ambulatory blood pressure leave ventricular mass index . Baroreceptor function measure non-invasive technique base combine computer analysis heart rate blood pressure measure portapres . 24-hour ambulatory blood pressure measure Spacelab monitor leave ventricular mass index measure direct M-mode echocardiogram . A longitudinal study conduct effect adequate treatment OSA baroreceptor function , daytime nocturnal blood pressure leave ventricular mass index . A cohort child OSA match group normal control follow period 12 month treatment disorder . Results expect show child OSA decrease baroreceptor sensitivity , elevate nocturnal blood pressure increase leave ventricular mass index effective therapy OSA , determine polysomnography , improve normalize baroreceptor sensitivity well nocturnal blood pressure lead decrease leave ventricular mass index .</detailed_description>
	<mesh_term>Cardiovascular Diseases</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<criteria>No eligibility criterion</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>